- Home
- BCG vs DYAI Comparison
BCG vs DYAI Comparison
Compare BCG & DYAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BCG
- DYAI
- Stock Information
- Founded
- BCG 2016
- DYAI 1979
- Country
- BCG United States
- DYAI United States
- Employees
- BCG N/A
- DYAI N/A
- Industry
- BCG
- DYAI Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- BCG
- DYAI Health Care
- Exchange
- BCG Nasdaq
- DYAI Nasdaq
- Market Cap
- BCG 32.5M
- DYAI 30.2M
- IPO Year
- BCG N/A
- DYAI 2004
- Fundamental
- Price
- BCG $1.71
- DYAI $0.97
- Analyst Decision
- BCG
- DYAI Strong Buy
- Analyst Count
- BCG 0
- DYAI 1
- Target Price
- BCG N/A
- DYAI $6.00
- AVG Volume (30 Days)
- BCG 18.7K
- DYAI 126.4K
- Earning Date
- BCG 11-13-2025
- DYAI 11-11-2025
- Dividend Yield
- BCG N/A
- DYAI N/A
- EPS Growth
- BCG N/A
- DYAI N/A
- EPS
- BCG N/A
- DYAI N/A
- Revenue
- BCG $173,961,000.00
- DYAI $4,135,078.00
- Revenue This Year
- BCG N/A
- DYAI $34.23
- Revenue Next Year
- BCG N/A
- DYAI $19.57
- P/E Ratio
- BCG N/A
- DYAI N/A
- Revenue Growth
- BCG 7.45
- DYAI 129.20
- 52 Week Low
- BCG $1.68
- DYAI $0.71
- 52 Week High
- BCG $6.55
- DYAI $2.20
- Technical
- Relative Strength Index (RSI)
- BCG 34.59
- DYAI 54.27
- Support Level
- BCG $1.75
- DYAI $0.95
- Resistance Level
- BCG $2.10
- DYAI $1.01
- Average True Range (ATR)
- BCG 0.10
- DYAI 0.06
- MACD
- BCG -0.01
- DYAI 0.01
- Stochastic Oscillator
- BCG 5.95
- DYAI 76.06
About BCG Binah Capital Group Inc. Common Stock
Binah Capital Group Inc formerly Wentworth Management Services LLC is a holding company that acquires and manages businesses in the wealth management industry. The company specializes in consolidating independent broker-dealers to capture economies of scale needed to service financial advisors in today's technology-enabled regulatory environment. Wentworth's core philosophy focuses on building long-term, productive relationships with its advisor base.
About DYAI Dyadic International Inc.
Dyadic International Inc is a worldwide biotechnology platform company. It has developed a gene expression platform for producing commercial quantities of industrial enzymes and other proteins and has licensed this technology to third parties, such as Abengoa Bioenergy, BASF, Codexis and others, for use in industrial (non-pharmaceutical) applications. This technology is based on the Thermothelomyces heterothallica fungus, which the company named C1.